GLP-3 (RT) — 10mg / 20mg

GLP-3 (RT) is a novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. In preclinical and early clinical research, this compound has demonstrated significant activity across multiple metabolic pathways, including glucose homeostasis, energy expenditure, and hepatic lipid reduction. Its tri-receptor mechanism represents an emerging frontier in metabolic peptide research, with investigators examining whether simultaneous activation of three receptor systems produces compounding effects on body composition and metabolic markers.